Test Catalog

Test Id : FMYPP

Myocarditis/Pericarditis Panel

Profile Information
A profile is a group of laboratory tests that are ordered and performed together under a single Mayo Test ID. Profile information lists the test performed, inclusive of the test fee, when a profile is ordered and includes reporting names and individual availability.

Test Id Reporting Name Available Separately Always Performed
CXB_1 Coxsackie B(1-6) Antibodies, S No Yes
ECH_1 Echovirus Antibody Panel, Serum No Yes
FINFL Influenza Types A and B Ab, Serum No Yes
FFCPA Chlamydophila pneumoniae Ab IgG/A/M No Yes

Method Name
A short description of the method used to perform the test

Complement Fixation (CF)/Immunoflourescence Assay (IFA)

NY State Available
Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name
Lists a shorter or abbreviated version of the Published Name for a test

Myocarditis/Pericarditis Panel

Specimen Type
Describes the specimen type validated for testing

Serum

Specimen Required
Defines the optimal specimen required to perform the test and the preferred volume to complete testing

Container/Tube:

Preferred: Red top

Acceptable: Serum gel

Specimen Volume: 3 mL

Collection instructions:

Draw blood in a plain red top tube(s), serum gel tube is acceptable. Spin down and send 3 mL of serum refrigerated in a plastic vial.

Specimen Minimum Volume
Defines the amount of sample necessary to provide a clinically relevant result as determined by the Testing Laboratory

2 mL

Reject Due To
Identifies specimen types and conditions that may cause the specimen to be rejected

Hemolysis Mild OK; Gross OK
Lipemia Mild OK; Gross OK
Icterus NA
Other NA

Specimen Stability Information
Provides a description of the temperatures required to transport a specimen to the performing laboratory, alternate acceptable temperatures are also included

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 14 days
Frozen 30 days
Ambient 7 days

Reference Values
Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.

MYOCARDITIS-PERICARDITIS PANEL

 

COXSACKIE B(1-6) ANTIBODIES, SERUM

 

    REFERENCE RANGE: <1:8

 

    INTERPRETIVE CRITERIA:

            <1:8 Antibody Not Detected

            > or = 1:8 Antibody Detected

 

Single titers of > or = 1:32 are indicative of recent infection. Titers of 1:8 or 1:16 may be indicative of either past or recent infection, since CF antibody levels persist for only a few months. A four-fold or greater increase in titer between acute and convalescent specimens confirms the diagnosis. There is considerable crossreactivity among enteroviruses; however, the highest titer is usually associated with the infecting serotype.

 

This test was developed and its performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

 

ECHOVIRUS ANTIBODIES, SERUM

 

    REFERENCE RANGE: <1:8

 

    INTERPRETIVE CRITERIA:

            <1:8 Antibody Not Detected

            > or = 1:8 Antibody Detected

 

Single titers > or = 1:32 are indicative of recent infection. Titers of 1:8 and 1:16 may be indicative of either past or recent infection, since CF antibody levels persist for only a few months. A four-fold or greater increase in titer between acute and convalescent specimens confirms the diagnosis. There is considerable crossreactivity among enteroviruses; however, the highest titer is usually associated with the infecting serotype.

 

This test was developed and its performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

 

INFLUENZA TYPES A AND B ANTIBODIES, SERUM

 

    REFERENCE RANGE: <1:8

 

    INTERPRETIVE CRITERIA:

            <1:8 Antibody Not Detected

            > or = 1:8 Antibody Detected

 

Single titers of > or = 1:64 are indicative of recent infection. Titers of 1:8 to 1:32 may be indicative of either past or recent infection, since CF antibody levels persist for only a few months. A four-fold or greater increase in titer between acute and convalescent specimens confirms the diagnosis.

 

This test was developed and its performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

 

CHLAMYDOPHILA PNEUMONIAE ANTIBODIES (IgG, IgA, IgM)

 

    REFERENCE RANGE:    IgG <1:64

                                          IgA <1:16

                                          IgM <1:10

 

The immunofluorescent detection of specific antibodies to Chlamydophila pneumoniae may be complicated by cross-reactive antibodies, non-specific antibody stimulation, or past exposure to similar organisms such as C. psittaci and Chlamydia trachomatis. IgM titers of 1:10 or greater usually indicate recent infection, and any IgG titer may indicate past exposure. IgA is typically present at low titers during primary infection, but may be elevated in recurrent exposures or in chronic infection.

PDF Report
Indicates whether the report includes an additional document with charts, images or other enriched information

No

Day(s) Performed
Outlines the days the test is performed. This field reflects the day that the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time before the test is performed. Some tests are listed as continuously performed, which means that assays are performed multiple times during the day.

Monday through Saturday

Report Available
The interval of time (receipt of sample at Mayo Clinic Laboratories to results available) taking into account standard setup days and weekends. The first day is the time that it typically takes for a result to be available. The last day is the time it might take, accounting for any necessary repeated testing.

2 to 9 days

Specimen Retention Time
Outlines the length of time after testing that a specimen is kept in the laboratory before it is discarded

6 weeks

Performing Laboratory Location
Indicates the location of the laboratory that performs the test

Quest Diagnostics

Fees
Several factors determine the fee charged to perform a test. Contact your U.S. or International Regional Manager for information about establishing a fee schedule or to learn more about resources to optimize test selection.

  • Authorized users can sign in to Test Prices for detailed fee information.
  • Clients without access to Test Prices can contact Customer Service 24 hours a day, seven days a week.
  • Prospective clients should contact their Regional Manager. For assistance, contact Customer Service.

Test Classification
Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR) product.

These assays were developed and their performance characteristics have been determined by Quest Diagnostics.  They have not been cleared or approved by FDA. These assays have been validated pursuant to the CLIA regulations and are used for clinical purposes.

CPT Code Information
Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Clinic Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.

CPT codes are provided by the performing laboratory.

86658 x 11

86710 x 2

86331 x 2

86632

LOINC® Information
Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the order and results codes of this test. LOINC values are provided by the performing laboratory.

Test Id Test Order Name Order LOINC Value
FMYPP Myocarditis/Pericarditis Panel Not Provided
Result Id Test Result Name Result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
Z2303 Coxsackie B1 Ab 5104-5
Z2304 Coxsackie B2 Ab 5106-0
Z2305 Coxsackie B3 Ab 5108-6
Z2306 Coxsackie B4 Ab 5110-2
Z2307 Coxsackie B5 Ab 5112-8
Z2308 Coxsackie B6 Ab 5114-4
Z2309 Echovirus 4 Ab 5143-3
Z2310 Echovirus 7 Ab 6922-9
Z2311 Echovirus 9 Ab 5147-4
Z2313 Echovirus 11 Ab 6708-2
Z2314 Echovirus 30 Ab 6392-5
Z0364 Influenza A Ab 5229-0
Z0365 Influenza B Ab 5230-8
Z5241 C. pneumoniae IgG 6913-8
Z5242 C. pneumoniae IgA 6912-0
Z5243 C. pneumoniae IgM 6914-6
Z5244 Interpretation 50612-1

Test Setup Resources

Setup Files
Test setup information contains test file definition details to support order and result interfacing between Mayo Clinic Laboratories and your Laboratory Information System.

Excel | Pdf

Sample Reports
Normal and Abnormal sample reports are provided as references for report appearance.

Normal Reports | Abnormal Reports

SI Sample Reports
International System (SI) of Unit reports are provided for a limited number of tests. These reports are intended for international account use and are only available through MayoLINK accounts that have been defined to receive them.

SI Normal Reports | SI Abnormal Reports